Xiaolei Cheng
Zhengzhou Key Laboratory Of Cardiovascular Aging, Henan Key Laboratory Of Chronic Disease Management, National Health Commission Key Laboratory Of Cardiovascular Regenerative Medicine
Zhengzhou, 451464, China
Zhengzhou, 451464, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Two birds with one stone: Targeting METTL3 ameliorates doxorubicin-induced endothelial premature senescence and atherosclerosis while potentiating its antitumor efficacy.
Journal: Free radical biology & medicine
Published: March 12, 2026
Bioinspired cardiac-targeted metal-organic framework nanozyme for modulating inflammatory responses in heart failure with preserved ejection fraction.
Journal: Frontiers in bioengineering and biotechnology
Published: November 12, 2025
Modified langendorff-free method for isolating cardiomyocytes and non-cardiomyocytes from adult mice.
Journal: BMC biotechnology
Published: November 05, 2025
YTHDC1 Orchestrates Telomerase Assembly via Scaffold-Mediated TERT-TERC Interaction.
Journal: Aging cell
Published: July 30, 2025
HuR coordinates systemic aging through platelet infiltration.
Journal: Nature communications
Published: July 07, 2025
Interferon Gamma and Secretory Immunoglobulin A Levels Decrease in Persistent Anal Condyloma Acuminatum Infection.
Journal: Annals of dermatology
Published: December 13, 2024
Engineered probiotic ameliorates hyperlipidemia and atherosclerosis by secreting PCSK9 nanobodies and regulating gut microbiota.
Journal: Bioengineering & translational medicine
Published: November 29, 2024
Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression.
Journal: Theranostics
Published: September 30, 2024
Deciphering the CREB-NR2B axis: Unraveling the crosstalk of insulin and TGF-β signalling in ameliorating postoperative cognitive dysfunction.
Journal: Life sciences
Published: September 22, 2024
Targeting OGF/OGFR signal to mitigate doxorubicin-induced cardiotoxicity.
Journal: Free radical biology & medicine
Published: June 09, 2024
Mitochondria-targeting Bimetallic Cluster Nanozymes Alleviate Neuropathic Pain Through Scavenging ROS and Reducing Inflammation.
Journal: Advanced healthcare materials
Published: April 30, 2024
Correction: Mitochondria-targeting nanozyme alleviating temporomandibular joint pain by inhibiting the TNFα/NF-κB/NEAT1 pathway.
Journal: Journal of materials chemistry. B
Published: December 06, 2023
Last Updated: 09/26/2026